CATHY MCGEE: Open Payments
NPI 1174900468 · PARKERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,014 in 61 payments from 11 companies in 2025. Trend: 2023 $1,283 · 2024 $908 · 2025 $1,014
Food & beverage: $1,014
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $168 |
| Teva Pharmaceuticals USA, Inc. | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| Lundbeck LLC | 4 | $83 |
| Neurocrine BioSciences, Inc. | 4 | $72 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| Alkermes, Inc. | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
Products named: VRAYLAR, REXULTI, CAPLYTA, INGREZZA, UZEDY, INVEGA SUSTENNA, ARISTADA, AUSTEDO XR.
Industry payments across WV — which companies pay providers there.
